| Original language | English |
|---|---|
| Pages (from-to) | 317-322 |
| Journal | Clinical Pharmacology and Therapeutics |
| Volume | 54 |
| Publication status | Published - 1993 |
Cite this
Ilett, K., Castleden, W. M., Vandongen, Y., Stacey, M. C., Butler, M. A., & Kadlubar, F. F. (1993). Acetylation phenotype and cytochrome P450IA2 phenotype are not associated with peripheral vascular disease. Clinical Pharmacology and Therapeutics, 54, 317-322.
@article{ff377c5d3b254920a61263d516cee613,
title = "Acetylation phenotype and cytochrome P450IA2 phenotype are not associated with peripheral vascular disease",
author = "Kenneth Ilett and W.M. Castleden and Y. Vandongen and M.C. Stacey and M.A. Butler and F.F. Kadlubar",
year = "1993",
language = "English",
volume = "54",
pages = "317--322",
journal = "Clinical pharmacology & therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
}
Ilett, K, Castleden, WM, Vandongen, Y, Stacey, MC, Butler, MA & Kadlubar, FF 1993, 'Acetylation phenotype and cytochrome P450IA2 phenotype are not associated with peripheral vascular disease' Clinical Pharmacology and Therapeutics, vol. 54, pp. 317-322.
Acetylation phenotype and cytochrome P450IA2 phenotype are not associated with peripheral vascular disease. / Ilett, Kenneth; Castleden, W.M.; Vandongen, Y.; Stacey, M.C.; Butler, M.A.; Kadlubar, F.F.
In: Clinical Pharmacology and Therapeutics, Vol. 54, 1993, p. 317-322.Research output: Contribution to journal › Article
TY - JOUR
T1 - Acetylation phenotype and cytochrome P450IA2 phenotype are not associated with peripheral vascular disease
AU - Ilett, Kenneth
AU - Castleden, W.M.
AU - Vandongen, Y.
AU - Stacey, M.C.
AU - Butler, M.A.
AU - Kadlubar, F.F.
PY - 1993
Y1 - 1993
M3 - Article
VL - 54
SP - 317
EP - 322
JO - Clinical pharmacology & therapeutics
JF - Clinical pharmacology & therapeutics
SN - 0009-9236
ER -
Ilett K, Castleden WM, Vandongen Y, Stacey MC, Butler MA, Kadlubar FF. Acetylation phenotype and cytochrome P450IA2 phenotype are not associated with peripheral vascular disease. Clinical Pharmacology and Therapeutics. 1993;54:317-322.